Newsletter
A neurotechnology company Reliefband debuted Reliefband Neurowave, the second generation of its wearable designed to combat the effects of VR-induced motion sickness. The Reliefband Neurowave will be hitting the market during the second quarter of the year, sporting an improved design and a $149.99 price tag. Additionally, the company has opened numerous Relief Stations in the VR Hall of the Las Vegas Convention Center where CES 2017 started earlier today. The stations were designed to provide people with a quick and drug-free solution to combat nausea and motion sickness often caused by a prolonged usage of VR products. Reliefband’s solution has been approved by the United States Food and Drug Administration (FDA) a year ago. Anyone interested in treating symptoms of virtual motion sickness can request a free relief at any Relief Station or Reliefband’s CES 2017 booth.
Reliefband is also launching a new website for educating consumers about causes of virtual motion sickness, related treatments, and preventive measures. The website explains how motion sickness is caused by sensory conflicts which occur when the eyes and ears are sending conflicting information to the brain. Seeing how a human brain naturally associates these conflicts of information with poisoning, it initiates preventive mechanisms, i.e. tries to get the body to vomit because it’s been tricked into believing that a poisonous substance has been ingested. The Reliefband Neurowave combats this natural mechanism by sending various pulses that stimulate the brain’s median nerve and consequently get it to block any nausea signals. The company claims this solution works within minutes and is more effective than any other method of combating symptoms associated with using VR products. Apart from working as a quick and drug-free cure for virtual motion sickness, the Reliefband Neurowave also acts as a preventive tool capable of stopping any symptoms of nausea before they appear.
In short, the second generation of Reliefband’s wearable is based on the same FDA-approved technology but ships in a slimmer case equipped with ten intensity settings instead of five. The Reliefband Neurowave is also equipped with hypoallergenic 316 surgical steel contacts which transmit pulses more efficiently than the contacts featured in the original Reliefband did. The company debuted its original product at CES 2016 last year and is now hoping that its Relief Stations will once again prove to be an effective marketing method seeing how they’ll allow consumers to witness the wearable’s capabilities first-hand.